Oral Steroids for Bursitis: Not Recommended as Primary Treatment
Oral corticosteroids should NOT be used as first-line therapy for acute inflammatory bursitis—local corticosteroid injection is the preferred approach when conservative measures fail. The evidence consistently demonstrates that direct injection into or around the affected bursa provides superior outcomes with fewer systemic complications compared to oral steroids.
Treatment Algorithm for Acute Inflammatory Bursitis
First-Line: Conservative Management (2-4 weeks)
- Rest and activity modification
- NSAIDs (naproxen 500 mg twice daily or meloxicam 7.5-15 mg daily) 1
- Ice application
- Physical therapy focusing on stretching and strengthening
Second-Line: Local Corticosteroid Injection
If conservative measures fail after 2-4 weeks, proceed with ultrasound-guided or landmark-based corticosteroid injection directly into the bursa 2:
Dosing by anatomic site:
- Shoulder/subacromial bursa: 10-20 mg triamcinolone (10 mg is as effective as 20 mg) 3, 2
- Trochanteric bursa: 12-24 mg betamethasone with 1% lidocaine (higher doses show better sustained relief) 4
- Olecranon bursa: Avoid injection due to high complication rates including skin atrophy and infection 5, 6
- Hip/iliopsoas bursa: Corticosteroid with local anesthetic mixture 7
Key Technical Points
- Ultrasound guidance increases accuracy and reduces procedural pain 2
- Mix corticosteroid with local anesthetic (typically 1% lidocaine 3-4 mL)
- Limit injections to every 3-4 months 8
- Never inject directly into tendons or ligaments 8
Why Oral Steroids Are Inappropriate
The provided guidelines address oral corticosteroids exclusively for systemic inflammatory conditions (asthma, polymyalgia rheumatica, ulcerative colitis, autoimmune encephalitis) 9, 10, 11—none recommend oral steroids for localized bursitis.
Critical distinctions:
- Bursitis is a localized inflammatory process requiring targeted treatment
- Oral steroids expose patients to systemic adverse effects (hyperglycemia, adrenal suppression, bone loss, infection risk) without addressing the local pathology effectively 2
- Local injection delivers higher concentrations directly to the inflamed tissue with minimal systemic absorption
Contraindications to Corticosteroid Injection
- Active infection (bacteremia or local septic bursitis—must rule out first)
- Recent fracture at injection site
- Anticoagulation (relative contraindication; consider aspiration only)
- Overlying skin infection
Special Considerations
Olecranon bursitis requires different management:
- Aseptic olecranon bursitis has higher complication rates with corticosteroid injection (skin atrophy, infection) 5, 6
- Conservative management is more effective and safer than injection for this specific site
- Aspiration alone (without steroid injection) does not increase infection risk 5
- Reserve injection only for refractory cases after extended conservative trial 6
Expected Outcomes
- Short-term relief: 60-77% of patients report improvement at 1-6 weeks 4
- Sustained benefit: 61% maintain improvement at 6 months with appropriate dosing 4
- Pain scores typically decrease from 7-8/10 to 2-3/10 at 6 months with proper injection technique 3
- 28.9% may eventually require surgery if injections fail 7
Common Pitfalls to Avoid
- Using oral steroids instead of local injection—wastes time and exposes patient to systemic risks
- Injecting olecranon bursa routinely—high complication rate at this site
- Using excessive corticosteroid doses—lower doses are equally effective (e.g., 10 mg vs 20 mg triamcinolone for shoulder) 3, 2
- Repeating injections too frequently—maintain 3-4 month intervals 8
- Failing to use ultrasound guidance when available—reduces accuracy and increases pain 2
Bottom line: If you're considering oral steroids for bursitis, you're choosing the wrong route of administration. Use local injection after conservative measures fail.